JPMorgan Financial Uncapped Accelerated Barrier Notes
JPMorgan Chase Financial Company LLC is offering uncapped accelerated barrier notes due March 18, 2031, fully guaranteed by JPMorgan Chase & Co. The notes provide at least a 1.35× upside leverage factor on the lesser performing of the Russell 2000® Index and the SPDR® S&P MidCap 400® ETF Trust, subject to a 70.00% barrier. If both underlyings finish above initial values, investors receive $1,000 plus leveraged appreciation; if either final value is below the barrier, losses accrue one-for-one versus the lesser performing underlying and investors can lose all principal. The notes are unsecured, non‑interest‑bearing, priced on or about March 13, 2026 with settlement about March 18, 2026. The estimated value at pricing is approximately $980 per $1,000 note and will not be less than $950 per $1,000 note.
Positive
- None.
Negative
- None.
Insights
Notes offer amplified upside on the lesser performing underlying but expose investors to full downside below a 70% barrier.
The structure provides a minimum 1.35 Upside Leverage Factor on the lesser performing Underlying; payment at maturity uses the Lesser Performing Underlying Return multiplied by that factor when both Underlyings finish higher. The Barrier Amount is 70.00% of each Initial Value and triggers one‑for‑one downside below that level.
Key dependencies include the closing Final Values on the Observation Date (March 13, 2031), the exact Upside Leverage Factor set at pricing, and the issuer/guarantor credit. Timing and payoff mechanics are governed by the pricing and observation dates stated in the supplement.
Primary investor risks: issuer/guarantor credit, lack of liquidity, and structural asymmetry between capped hedging costs and uncapped payoff.
The notes are unsecured obligations of JPMorgan Financial and fully guaranteed by JPMorgan Chase & Co., so creditworthiness of both entities affects value. Secondary market prices are expected to be materially lower than original issue price due to embedded costs and internal funding rates, per the supplement.
Secondary market liquidity depends on JPMS willingness to repurchase; the estimated value ($980) is model‑based and lower than the price to public. Investors face potential conflicts from issuer hedging and should consider illiquidity and tax treatment described in the supplement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What payout does AMJB's Uncapped Accelerated Barrier Note provide at maturity?
When are AMJB notes priced and settled?
What is the barrier and what happens if it is breached for AMJB notes?
What estimated value should investors expect relative to the issue price?
Are the AMJB notes protected by FDIC or do they pay interest/dividends?
What are the main risks specific to these notes?
AI-generated analysis. How Rhea-AI works. Not financial advice.